What is the ticker symbol for Editas Medicine?

Editas Medicine trades under the ticker EDIT on NASDAQ.

What sector does Editas Medicine operate in?

Editas Medicine is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze EDIT in a portfolio?

PortView shows EDIT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Editas Medicine (EDIT) Stock Analysis

NASDAQHealthcareBiotechnology

$3.00-2.43%

1-year price historyRange $1.67 – $4.15

52-week range$3.00

$1.66$4.54

What Editas Medicine does

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Key metrics

Market cap

$459.68M

P/E (TTM)

-3.99

EPS (TTM)

$-0.75

Beta

2.06

Dividend yield

0.00%

Revenue / share

$0.39

50-day avg

$2.99

200-day avg

$2.60

52-week high

$4.54

52-week low

$1.66

CEO

Gilmore O'Neill

ETFs linked to EDIT

Broad-market and Healthcare sector ETFs an investor holding Editas Medicine is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how EDIT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze EDIT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Editas Medicine?: Editas Medicine trades under the ticker EDIT on NASDAQ.
Which exchange is EDIT listed on?: EDIT is listed on NASDAQ.
What sector does Editas Medicine operate in?: Editas Medicine is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze EDIT in a portfolio?: PortView shows EDIT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.